IL139637A0 - Mechanical stress induced genes, expression products therefrom, and uses thereof - Google Patents

Mechanical stress induced genes, expression products therefrom, and uses thereof

Info

Publication number
IL139637A0
IL139637A0 IL13963799A IL13963799A IL139637A0 IL 139637 A0 IL139637 A0 IL 139637A0 IL 13963799 A IL13963799 A IL 13963799A IL 13963799 A IL13963799 A IL 13963799A IL 139637 A0 IL139637 A0 IL 139637A0
Authority
IL
Israel
Prior art keywords
expression products
genes
mechanical stress
stress induced
products therefrom
Prior art date
Application number
IL13963799A
Other languages
English (en)
Original Assignee
Quark Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quark Biotech Inc filed Critical Quark Biotech Inc
Publication of IL139637A0 publication Critical patent/IL139637A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
IL13963799A 1998-05-15 1999-05-14 Mechanical stress induced genes, expression products therefrom, and uses thereof IL139637A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8567398P 1998-05-15 1998-05-15
PCT/US1999/011066 WO1999060164A1 (en) 1998-05-15 1999-05-14 Mechanical stress induced genes, expression products therefrom, and uses thereof

Publications (1)

Publication Number Publication Date
IL139637A0 true IL139637A0 (en) 2002-02-10

Family

ID=22193209

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13963799A IL139637A0 (en) 1998-05-15 1999-05-14 Mechanical stress induced genes, expression products therefrom, and uses thereof
IL139637A IL139637A (en) 1998-05-15 2000-11-13 Mechanical stress induced genes, expression products therefrom and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL139637A IL139637A (en) 1998-05-15 2000-11-13 Mechanical stress induced genes, expression products therefrom and uses thereof

Country Status (9)

Country Link
EP (1) EP1082463B1 (de)
JP (1) JP2002535956A (de)
AT (1) ATE350486T1 (de)
AU (1) AU4004699A (de)
CA (1) CA2332150A1 (de)
DE (1) DE69934688T2 (de)
IL (2) IL139637A0 (de)
WO (1) WO1999060164A1 (de)
ZA (1) ZA200006613B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020151514A1 (en) * 1998-05-11 2002-10-17 Paz Einat Genes associated with mechanical stress, expression products therefrom, and uses thereof
US7259253B2 (en) 1999-05-14 2007-08-21 Quark Biotech, Inc. Genes associated with mechanical stress, expression products therefrom, and uses thereof
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US6986988B2 (en) 1999-10-06 2006-01-17 Quark Biotech, Inc. Method for enrichment of natural antisense messenger RNA
WO2001025488A2 (en) * 1999-10-06 2001-04-12 Quark Biotech, Inc. Method for enrichment of natural antisense messenger rna
US6468749B1 (en) 2000-03-30 2002-10-22 Quark Biotech, Inc. Sequence-dependent gene sorting techniques
WO2002046753A1 (fr) * 2000-12-06 2002-06-13 Takara Bio Inc. Reseau d'adn fonctionnel
WO2002077019A1 (en) * 2001-03-23 2002-10-03 Dana Farber Cancer Institute,Inc. Methods and compositions for modulating tumor suppression
US20030191073A1 (en) 2001-11-07 2003-10-09 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
BE1014949A3 (fr) * 2001-08-14 2004-07-06 Probiox Procede de detection de stress oxydant et trousse pour sa mise en oeuvre.
US7226594B2 (en) 2001-11-07 2007-06-05 Agensys, Inc. Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
AU2004274861A1 (en) * 2003-06-06 2005-03-31 Wyeth Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby
CN101076348A (zh) 2004-10-08 2007-11-21 克里纽沃药物有限公司 用于在受试者中诱导黑素原生成的组合物和方法
US8350009B2 (en) 2005-03-31 2013-01-08 Agensys, Inc. Antibodies and related molecules that bind to 161P2F10B proteins
EP1863848A4 (de) 2005-03-31 2009-09-23 Agensys Inc An 161p2f10b-proteine bindende antikörper und verwandte moleküle
CA2619174C (en) 2005-08-15 2016-12-20 Vaxin, Inc. Immunization of avians by administration of non-replicating vectored vaccines
FR2893328B1 (fr) * 2005-11-17 2014-01-31 Lvmh Rech Procede pour depister des marqueurs impliques dans la resistance de keratinocytes a des deformations mecaniques.
PT2056855E (pt) 2006-08-31 2014-12-12 Clinuvel Pharmaceuticals Ltd Derivados de alfa-msh para o tratamento de fotodermatoses
HUE038611T2 (hu) 2008-03-27 2018-10-29 Clinuvel Pharmaceuticals Ltd Vitiligo terápia
TWI504410B (zh) 2010-02-08 2015-10-21 Agensys Inc 結合至１６１ｐ２ｆ１０ｂ蛋白之抗體藥物結合物（ａｄｃ）
EP2487185A1 (de) 2011-02-11 2012-08-15 Clinuvel Pharmaceuticals Limited Hexapeptid mit verbesserter Aktivität bei der Reparatur von zellulärer DNA von Dermiszellen
ES2645156T3 (es) 2011-03-21 2017-12-04 Altimmune Inc. Agente terapéutico inmunológico de acción rápida y prolongada
ES2626297T3 (es) 2011-08-12 2017-07-24 Merial, Inc. Preservación asistida por vacío de productos biológicos, en particular de vacunas
WO2014012090A1 (en) 2012-07-13 2014-01-16 The Broad Institute, Inc. Molecular sleds comprising a positively-charged amino acid sequence and a molecular cargo and uses thereof
JP2015527889A (ja) 2012-07-25 2015-09-24 ザ ブロード インスティテュート， インコーポレイテッド 誘導可能なｄｎａ結合タンパク質およびゲノム撹乱ツール、ならびにそれらの適用
WO2014121104A1 (en) * 2013-01-31 2014-08-07 The Regents Of The University Of California Pooled genetic perturbation effects
US11332719B2 (en) 2013-03-15 2022-05-17 The Broad Institute, Inc. Recombinant virus and preparations thereof
WO2015057671A1 (en) 2013-10-14 2015-04-23 The Broad Institute, Inc. Artificial transcription factors comprising a sliding domain and uses thereof
JP6545084B2 (ja) * 2015-11-11 2019-07-17 株式会社Adeka 潤滑油組成物及びその製造方法
WO2022198126A1 (en) * 2021-03-19 2022-09-22 Washington University Methods for generating mechanically-responsive cells and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9204303A (es) * 1991-07-23 1993-11-01 Rhone Poulenc Rorer Int Factor regulador del crecimiento de osteoclasto.
US5445941A (en) * 1993-06-21 1995-08-29 Eli Lilly And Company Method for screening anti-osteoporosis agents
US5763416A (en) * 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5968770A (en) * 1995-02-10 1999-10-19 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target
US5861249A (en) * 1996-04-23 1999-01-19 Cold Spring Harbor Laboratory Assays and reagents for identifying modulators of cdc25-mediated mitotic activation

Also Published As

Publication number Publication date
CA2332150A1 (en) 1999-11-25
IL139637A (en) 2009-09-22
WO1999060164A1 (en) 1999-11-25
EP1082463A4 (de) 2003-05-21
EP1082463B1 (de) 2007-01-03
ATE350486T1 (de) 2007-01-15
AU4004699A (en) 1999-12-06
DE69934688D1 (de) 2007-02-15
JP2002535956A (ja) 2002-10-29
EP1082463A1 (de) 2001-03-14
DE69934688T2 (de) 2007-10-18
ZA200006613B (en) 2002-02-14

Similar Documents

Publication Publication Date Title
IL139637A0 (en) Mechanical stress induced genes, expression products therefrom, and uses thereof
WO2002040634A3 (en) Expression miniarrays and uses thereof
HUP0401591A2 (hu) Új receptor-nukleinsavak és- polipeptidek
EP1005540A4 (de) Ikk-beta proteines, nukleinsäuren und verfahren
EP0837928A4 (de) Zusammensetzungen aus rekombinierten poxvirus-cytomegalovirus und ihre verwendung
DE60233485D1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
EP0831885A4 (de) Verfahren und verwendung von bindegewebs-wachstumsfaktor als induzierendes mittel
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
WO2000018899A3 (en) Angiotensin converting enzyme homolog and its use
GB0018901D0 (en) Peptides presented by cells
EP1163515A4 (de) Therapeutische und diagnostische mittel für krankheiter mit gestörter glukose-tolerenz
AU2003259222A1 (en) Method of diagnosing alzheimer's disease
WO1999051186A3 (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
EP1005539A4 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
MXPA03010100A (es) Tratamiento de la piel.
HUP0003684A2 (hu) Alzheimer-kór diagnosztizálására szolgáló vizsgálat
WO2002018574A3 (en) Human interleukin-four induced protein
PT831899E (pt) Composições de poxvírus-calicivírus recombinantes e suas utilizações
EP1019092A4 (de) Therapeutische und diagnostische mittel für krankheiten mit gestörter glukose-toleranz
ATE527376T1 (de) Pna-sonden, sondensätze, verfahren und kits im zusammenhang mit dem nachweis von candida
WO2003063689A3 (en) Islr gene and its association with osteoarthritis and other bone and cartilage disorders, expression products derived therefrom, and uses thereof
WO2003103597A3 (en) DIAGNOSIS AND TREATMENT OF DIABETES AND INSULIN RESISTANCE
EP1078003A4 (de) Plasmin-inhibitoren aus der australischen braunen schlange (pseudonaja textilis textilis)
WO2003103601A3 (en) DIAGNOSIS AND TREATMENT METHODS FOR DIABETES AND INSULIN RESISTANCE
ATE236250T1 (de) Antisense-sequenzen für die hemmung der expression des adhäsionsmoleküls icam-1